{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:12:09Z","timestamp":1791569529257,"version":"4.3.4"},"reference-count":205,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101003688"],"award-info":[{"award-number":["101003688"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004418","name":"Vrije Universiteit Brussel","doi-asserted-by":"publisher","award":["OZR3863BOF"],"award-info":[{"award-number":["OZR3863BOF"]}],"id":[{"id":"10.13039\/501100004418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Emerging infectious diseases are one of the main threats to public health, with the potential to cause a pandemic when the infectious agent manages to spread globally. The first major pandemic to appear in the 20th century was the influenza pandemic of 1918, caused by the influenza A H1N1 strain that is characterized by a high fatality rate. Another major pandemic was caused by the human immunodeficiency virus (HIV), that started early in the 20th century and remained undetected until 1981. The ongoing HIV pandemic demonstrated a high mortality and morbidity rate, with discrepant impacts in different regions around the globe. The most recent major pandemic event, is the ongoing pandemic of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has caused over 5.7 million deaths since its emergence, 2\u2009years ago. The aim of this work is to highlight the main determinants of the emergence, epidemic response and available countermeasures of these three pandemics, as we argue that such knowledge is paramount to prepare for the next pandemic. We analyse these pandemics\u2019 historical and epidemiological contexts and the determinants of their emergence. Furthermore, we compare pharmaceutical and non-pharmaceutical interventions that have been used to slow down these three pandemics and zoom in on the technological advances that were made in the progress. Finally, we discuss the evolution of epidemiological modelling, that has become an essential tool to support public health policy making and discuss it in the context of these three pandemics. While these pandemics are caused by distinct viruses, that ignited in different time periods and in different regions of the globe, our work shows that many of the determinants of their emergence and countermeasures used to halt transmission were common. Therefore, it is important to further improve and optimize such approaches and adapt it to future threatening emerging infectious diseases.<\/jats:p>","DOI":"10.3389\/fmicb.2022.889643","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T10:31:27Z","timestamp":1654165887000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2"],"prefix":"10.3389","volume":"13","author":[{"given":"Mafalda N. S.","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pingarilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Torneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia G.","family":"Seabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J. K.","family":"Libin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Abecasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"100449","DOI":"10.1016\/j.epidem.2021.100449","article-title":"Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories","volume":"35","author":"Abrams","year":"2021","journal-title":"Epidemics"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5582\/ddt.2020.03008","article-title":"Treatment of SARS-CoV-2: how far have we reached?","volume":"14","author":"Ahsan","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"ref3","year":"2021"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"W634","DOI":"10.1093\/nar\/gkp455","article-title":"A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences","volume":"37","author":"Alcantara","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s41467-017-00923-8","article-title":"Global hotspots and correlates of emerging zoonotic diseases","volume":"8","author":"Allen","year":"2017","journal-title":"Nat. Commun."},{"key":"ref6","author":"Alnwick","year":"2007"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Andreani","year":"2020","journal-title":"Antivir. Res."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41591-021-01347-0","article-title":"SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies","volume":"27","author":"Andreano","year":"2021","journal-title":"Nat. Med."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/jmv.23898","article-title":"Antiretroviral drug resistance among antiretroviral-na\u00efve and treatment experienced patients infected with HIV in Iran","volume":"86","author":"Baesi","year":"2014","journal-title":"J. Med. Virol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/00007435-200011000-00029","article-title":"STDSIM: a microsimulation model for decision support in the control of HIV and other STDs","volume":"27","author":"Bakker","year":"2000","journal-title":"Sex. Transm. Dis."},{"key":"ref13","first-page":"E115","article-title":"History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines","volume":"57","author":"Barberis","year":"2016","journal-title":"J. Prev. Med. Hyg."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.03.024","article-title":"SARS-CoV: lessons for global health","volume":"133","author":"Baric","year":"2008","journal-title":"Virus Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/vaccines9020147","article-title":"SARS-CoV-2 mRNA vaccines: immunological mechanism and Beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41564-020-0771-4","article-title":"Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic","volume":"5","author":"Boni","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1038\/s41467-021-26239-2","article-title":"Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19","volume":"12","author":"Boras","year":"2021","journal-title":"Nat. Commun."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1473-3099(07)70029-4","article-title":"Transmission of influenza A in human beings","volume":"7","author":"Brankston","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12879-017-2316-x","article-title":"The therapeutic HIV Env C5\/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I\/II clinical study","volume":"17","author":"Brekke","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3201\/eid0303.970301","article-title":"Recombination in HIV: an important viral evolutionary strategy","volume":"3","author":"Burke","year":"1997","journal-title":"Emerg. Infect. Dis."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/S2666-5247(20)30205-6","article-title":"Mass testing for COVID-19","volume":"1","author":"Burki","year":"2020","journal-title":"Lancet Microbe"},{"key":"ref22","year":""},{"key":"ref23","year":""},{"key":"ref24","year":""},{"key":"ref25","year":""},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e1000656","DOI":"10.1371\/journal.pcbi.1000656","article-title":"FluTE, a publicly available stochastic influenza epidemic simulation model","volume":"6","author":"Chao","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"ref27","author":"Charles","year":"2008"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"9042","DOI":"10.1038\/s41598-021-87692-z","article-title":"Climate and the spread of COVID-19","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bib\/bbaa297","article-title":"Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities","volume":"22","author":"Chiara","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13054-019-2491-9","article-title":"Influenza virus-related critical illness: prevention, diagnosis, treatment","volume":"23","author":"Chow","year":"2019","journal-title":"Crit. Care"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.meegid.2016.08.031","article-title":"HIV-1 drug resistance and resistance testing","volume":"46","author":"Clutter","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1172\/JCI34706","article-title":"The spread, treatment, and prevention of HIV-1: evolution of a global pandemic","volume":"118","author":"Cohen","year":"2008","journal-title":"J. Clin. Invest."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12879-021-06092-w","article-title":"A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies","volume":"21","author":"Coletti","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"21885","DOI":"10.1038\/s41598-020-78540-7","article-title":"CoMix: comparing mixing patterns in the Belgian population during and after lockdown","volume":"10","author":"Coletti","year":"2020","journal-title":"Sci. Rep."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-021-04130-w","article-title":"Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave","volume":"600","author":"Davis","year":"2021","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nrd2175","article-title":"Antiviral agents active against influenza A viruses","volume":"5","author":"De Clercq","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/QAD.0b013e328354622a","article-title":"The evolving epidemiology of HIV\/AIDS","volume":"26","author":"De Cock","year":"2012","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12879-017-2934-3","article-title":"The impact of regular school closure on seasonal influenza epidemics: a data-driven spatial transmission model for Belgium","volume":"18","author":"De","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e1009571","DOI":"10.1371\/journal.ppat.1009571","article-title":"Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York City","volume":"17","author":"Dellicour","year":"2021","journal-title":"PLoS Pathog."},{"key":"ref41","volume-title":"Mathematical Tools for Understanding Infectious Disease Dynamics.","author":"Diekmann","year":"2013"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e2673","DOI":"10.1097\/MD.0000000000002673","article-title":"The F4\/AS01B HIV-1 vaccine candidate is safe and immunogenic, but does not show viral efficacy in antiretroviral therapy-naive, HIV-1-infected adults","volume":"95","author":"Dinges","year":"2016","journal-title":"Medicine"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1038\/s41467-020-16585-y","article-title":"Modeling mitigation of influenza epidemics by baloxavir","volume":"11","author":"Du","year":"2020","journal-title":"Nat. Commun."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e1002425","DOI":"10.1371\/journal.pcbi.1002425","article-title":"Measured dynamic social contact patterns explain the spread of H1N1v influenza","volume":"8","author":"Eames","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"ref46","year":"2022"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1098\/rsif.2010.0216","article-title":"Spatial dynamics of the 1918 influenza pandemic in England, Wales and the United States","volume":"8","author":"Eggo","year":"2011","journal-title":"J. R. Soc. Interface"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jama.1996.03530410043031","article-title":"Survival From early, intermediate, and late stages of HIV infection","volume":"275","author":"Enger","year":"1996","journal-title":"JAMA"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12977-015-0151-y","article-title":"HIV-1 tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial","volume":"12","author":"Ensoli","year":"2015","journal-title":"Retrovirology"},{"key":"ref50","year":"2022"},{"key":"ref51","year":"2022"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.1256739","article-title":"The early spread and epidemic ignition of HIV-1 in human populations","volume":"346","author":"Faria","year":"2014","journal-title":"Science"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/QAI.0b013e3182973966","article-title":"Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States","volume":"64","author":"Farnham","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref54","year":"2021"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e1004093","DOI":"10.1371\/journal.pcbi.1004093","article-title":"HIV competition dynamics over sexual networks: first comer advantage conserves founder effects","volume":"11","author":"Ferdinandy","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic","volume":"442","author":"Ferguson","year":"2006","journal-title":"Nature"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"eabb6936","DOI":"10.1126\/science.abb6936","article-title":"Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing","volume":"368","author":"Ferretti","year":"2020","journal-title":"Science"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.idc.2014.05.001","article-title":"Global epidemiology of HIV","volume":"28","author":"Fettig","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"Fonner","year":"2016","journal-title":"AIDS"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/aje\/kwr122","article-title":"Influenza transmission in households during the 1918 pandemic","volume":"174","author":"Fraser","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1073\/pnas.0307506101","article-title":"Factors that make an infectious disease outbreak controllable","volume":"101","author":"Fraser","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMp038194","article-title":"The discovery of HIV as the cause of AIDS","volume":"349","author":"Gallo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrmicro794","article-title":"The role of sexually transmitted diseases in HIV transmission","volume":"2","author":"Galvin","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1073\/pnas.0601266103","article-title":"Mitigation strategies for pandemic influenza in the United States","volume":"103","author":"Germann","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref65","year":"2021"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.epidem.2012.04.002","article-title":"Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia","volume":"4","author":"Graw","year":"2012","journal-title":"Epidemics"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1002\/eji.200737441","article-title":"A history of AIDS: looking back to see ahead","volume":"37","author":"Greene","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref68","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198540663.001.0001","volume-title":"Metapopulation Ecology.","author":"Hanski","year":"1999"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"e1007893","DOI":"10.1371\/journal.pcbi.1007893","article-title":"Calibration of individual-based models to epidemiological data: a systematic review","volume":"16","author":"Hazelbag","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","article-title":"The origin and diversity of the HIV-1 pandemic","volume":"18","author":"Hemelaar","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1473-3099(18)30647-9","article-title":"Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis","volume":"19","author":"Hemelaar","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"14696","DOI":"10.1038\/s41598-021-94289-z","article-title":"Comparison of two simulators for individual based models in HIV epidemiology in a population with HSV 2 in Yaound\u00e9 (Cameroon)","volume":"11","author":"Hendrickx","year":"2021","journal-title":"Sci. Rep."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e1009146","DOI":"10.1371\/journal.pcbi.1009146","article-title":"OpenABM-Covid19\u2014an agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing","volume":"17","author":"Hinch","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"ref75","year":"2021"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.60067","article-title":"Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A\/H3N2 evolution","volume":"9","author":"Huddleston","year":"2020","journal-title":"Elife"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/bib\/bbaa232","article-title":"Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research","volume":"22","author":"Hufsky","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/emph\/eoy024","article-title":"The influenza of 1918","volume":"2018","author":"Humphreys","year":"2018","journal-title":"Evol. Med. Public Health"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IDR.S105473","article-title":"Drug resistance in influenza a virus: the epidemiology and management","volume":"10","author":"Hussain","year":"2017","journal-title":"Infect Drug Resist."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/QAI.0000000000000926","article-title":"Dendritic cell immunotherapy for HIV-1 infection using autologous HIV-1 RNA","volume":"72","author":"Jacobson","year":"","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/QAI.0000000000000830","article-title":"The safety and immunogenicity of an interleukin-12\u2013enhanced multiantigen DNA vaccine delivered by electroporation for the treatment of HIV-1 infection","volume":"71","author":"Jacobson","year":"","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2471\/BLT.11.088815","article-title":"The classical definition of a pandemic is not elusive","volume":"89","author":"Kelly","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0092-8240(05)80040-0","article-title":"Contributions to the mathematical theory of epidemics\u2014I","volume":"53","author":"Kermack","year":"","journal-title":"Bull. Math. Biol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF02464424","article-title":"Contributions to the mathematical theory of epidemics\u2014II. The problem of endemicity","volume":"53","author":"Kermack","year":"","journal-title":"Bull. Math. Biol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.15.367.68","article-title":"Contributions to the mathematical theory of epidemics\u2014III. Further studies of the problem of endemicity","volume":"53","author":"Kermack","year":"","journal-title":"Bull. Math. Biol."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QAI.0000000000000605","article-title":"Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization","volume":"69","author":"Kerr","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e1009149","DOI":"10.1371\/journal.pcbi.1009149","article-title":"Covasim: an agent-based model of COVID-19 dynamics and interventions","volume":"17","author":"Kerr","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s11658-020-00211-2","article-title":"Metabolic host response and therapeutic approaches to influenza infection","volume":"25","author":"Keshavarz","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1038\/s41598-018-21081-x","article-title":"Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009\u20132016: A nationwide study","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"ref90","author":"Kompella","year":"2020"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"e8932","DOI":"10.7759\/cureus.8932","article-title":"Potential zoonotic origins of SARS-CoV-2 and insights for preventing future pandemics through one health approach","volume":"12","author":"Konda","year":"2020","journal-title":"Cureus"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1126\/science.288.5472.1789","article-title":"Timing the ancestor of the HIV-1 pandemic strains","volume":"288","author":"Korber","year":"2000","journal-title":"Science"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/irv.12446","article-title":"Influenza antivirals currently in late-phase clinical trial","volume":"11","author":"Koszalka","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S1473-3099(20)30144-4","article-title":"Early dynamics of transmission and control of COVID-19: a mathematical modelling study","volume":"20","author":"Kucharski","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"139278","DOI":"10.1016\/j.scitotenv.2020.139278","article-title":"A chronicle of SARS-CoV-2: part-I \u2013 epidemiology, diagnosis, prognosis, transmission and treatment","volume":"734","author":"Kumar","year":"2020","journal-title":"Sci. Total Environ."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza and antiviral resistance: an overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"e069761","DOI":"10.1136\/bmj-2021-069761","article-title":"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study","volume":"376","author":"Lauring","year":"2022","journal-title":"BMJ"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/QCO.0000000000000498","article-title":"Neuraminidase inhibitor resistance in influenza: a clinical perspective","volume":"31","author":"Lee","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/QAI.0000000000001555","article-title":"The effect of PrEP on HIV incidence among men who have sex with men in the context of condom use, treatment as prevention, and seroadaptive practices","volume":"77","author":"LeVasseur","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref100","author":"Libin","year":"2020"},{"key":"ref101","article-title":"Bayesian best-arm identification for selecting influenza mitigation strategies","volume-title":"European Conference of Machine Learning","author":"Libin","year":"2018"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"e1008688","DOI":"10.1371\/journal.pcbi.1008688","article-title":"Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics","volume":"17","author":"Libin","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"ref103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1515\/9781400841356.227","article-title":"The web of human sexual contacts","volume-title":"The Structure and Dynamics of Networks","author":"Liljeros","year":"2011"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1371\/journal.pmed.0040015","article-title":"Antiviral resistance and the control of pandemic influenza","volume":"4","author":"Lipsitch","year":"2007","journal-title":"PLoS Med."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"e0005022","DOI":"10.1371\/journal.pone.0005022","article-title":"Panorama phylogenetic diversity and distribution of type A influenza virus","volume":"4","author":"Liu","year":"2009","journal-title":"PLoS One"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/B978-0-12-809633-8.21501-X","article-title":"Human coronavirus-229E, -OC43, -NL63, and -HKU1 (coronaviridae)","author":"Liu","year":"2021","journal-title":"Encyclopedia of Virology"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"n1088","DOI":"10.1136\/bmj.n1088","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: transmission, prevention, and potential therapeutic opportunities","volume":"508","author":"Lotfi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1086\/322662","article-title":"Observations on mortality during the 1918 influenza pandemic","volume":"33","author":"Luk","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/infdis\/jiv582","article-title":"Therapeutic vaccination with dendritic cells loaded with autologous HIV type 1\u2013infected apoptotic cells","volume":"213","author":"Macatangay","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/jama.2021.0585","article-title":"Neutralizing monoclonal antibody for mild to moderate COVID-19","volume":"325","author":"Malani","year":"2021","journal-title":"JAMA"},{"key":"ref112","first-page":"3","article-title":"Properties of coronavirus and SARS-CoV-2","volume":"42","author":"Malik","year":"2020","journal-title":"Malays. J. Pathol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/jama.298.6.644","article-title":"Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic","volume":"298","author":"Markel","year":"2007","journal-title":"JAMA"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"E64","DOI":"10.15167\/2421-4248\/jpmh2019.60.1.1205","article-title":"The Spanish influenza pandemic: a lesson from history 100 years after 1918","volume":"60","author":"Martini","year":"2019","journal-title":"J. Prev. Med. Hyg."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cnur.2019.02.006","article-title":"Emerging infectious diseases","volume":"54","author":"McArthur","year":"2019","journal-title":"Nurs. Clin. North Am."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1126\/science.1175570","article-title":"Optimizing influenza vaccine distribution","volume":"325","author":"Medlock","year":"2009","journal-title":"Science"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.cmi.2018.07.001","article-title":"The great influenza centennial\u2014what have we learned about the epidemiology and prevention of transmission?","volume":"24","author":"Mermel","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature03063","article-title":"Transmissibility of 1918 pandemic influenza","volume":"432","author":"Mills","year":"2004","journal-title":"Nature"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/pathogens10070835","article-title":"Determinants of HIV-1 late presentation in patients followed in Europe","volume":"10","author":"Miranda","year":"2021","journal-title":"Pathogens"},{"key":"ref120","year":"2021"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-011110-130254","article-title":"Pathogenic mechanisms of HIV disease","volume":"6","author":"Moir","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref122","first-page":"319","article-title":"Lymphadenopathy associated virus and its etiological role in AIDS","volume":"15","author":"Montagnier","year":"1984","journal-title":"Princess Takamatsu Symp."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"e1008849","DOI":"10.1371\/journal.pcbi.1008849","article-title":"Modelling optimal vaccination strategy for SARS-CoV-2 in the UK","volume":"17","author":"Moore","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1086\/511989","article-title":"The 1918 influenza pandemic: insights for the 21st century","volume":"195","author":"Morens","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.cell.2020.08.021","article-title":"Emerging pandemic diseases: how we got to COVID-19","volume":"182","author":"Morens","year":"2020","journal-title":"Cell"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/v9110330","article-title":"Characterization of nucleoside reverse transcriptase inhibitor-associated mutations in the RNase H region of HIV-1 subtype C infected individuals","volume":"9","author":"Ngcapu","year":"2017","journal-title":"Viruses"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12879-019-3750-8","article-title":"A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918-1919","volume":"19","author":"Nickol","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ve\/veab064\/6315289","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume":"7","author":"O\u2019Toole","year":"2021","journal-title":"Virus Evol."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41591-021-01472-w","article-title":"The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology","volume":"27","author":"Oude Munnink","year":"2021","journal-title":"Nat. Med."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"20200982","DOI":"10.1098\/rsif.2020.0982","article-title":"COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production","volume":"18","author":"Palmer","year":"2021","journal-title":"J. R. Soc. Interface"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"e0185866","DOI":"10.1371\/journal.pone.0185866","article-title":"Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users","volume":"12","author":"Paraschiv","year":"2017","journal-title":"PLoS One"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"mRNA vaccines for COVID-19: what, why and how","volume":"17","author":"Park","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.idc.2014.06.001","article-title":"Antiretroviral therapy: current drugs","volume":"28","author":"Pau","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-02457-y","article-title":"Face masks for COVID pass their largest test yet","author":"Peeples","year":"2021","journal-title":"Nature"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"100924","DOI":"10.1016\/j.eclinm.2021.100924","article-title":"COVID-19: rapid antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation of sensitivity and specificity for mass-testing","volume":"36","author":"Peto","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/v12030268","article-title":"Molecular epidemiology of HIV-1 infected migrants followed up in Portugal: trends between 2001\u20132017","volume":"12","author":"Pimentel","year":"2020","journal-title":"Viruses"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"Pineda-Pe\u00f1a","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"e0218226","DOI":"10.1371\/journal.pone.0218226","article-title":"Drivers of HIV-1 transmission: the Portuguese case","volume":"14","author":"Pineda-Pe\u00f1a","year":"2019","journal-title":"PLoS One"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/v12111238","article-title":"Increasing prevalence of HIV-1 transmitted drug resistance in Portugal: implications for first line treatment recommendations","volume":"12","author":"Pingarilho","year":"2020","journal-title":"Viruses"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1473-3099(13)70343-8","article-title":"Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4\u00d7: a phase 2 randomised, double-blind, placebo-controlled trial","volume":"14","author":"Pollard","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.arcmed.2020.04.020","article-title":"A review of current interventions for COVID-19 prevention","volume":"51","author":"Pradhan","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1126\/science.abf0521","article-title":"Airborne transmission of SARS-CoV-2","volume":"370","author":"Prather","year":"2020","journal-title":"Science"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1016\/S2468-2667(20)30073-6","article-title":"The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study","volume":"5","author":"Prem","year":"2020","journal-title":"Lancet Public Health"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1590\/S0034-89102006000200023","article-title":"Worldwide molecular epidemiology of HIV","volume":"40","author":"Requejo","year":"2006","journal-title":"Rev. Saude Publica"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"e1008776","DOI":"10.1371\/journal.pcbi.1008776","article-title":"Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic","volume":"17","author":"Richard","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"ref148","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/ije\/dyab027","article-title":"Data resource profile: COVerAGE-DB: a global demographic database of COVID-19 cases and deaths","volume":"50","author":"Riffe","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18773\/austprescr.2019.013","article-title":"Influenza: overview on prevention and therapy","volume":"42","author":"Robson","year":"2019","journal-title":"Aust. Prescr."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"202240","DOI":"10.1098\/rsos.202240","article-title":"The trade-off between mobility and vaccination for COVID-19 control: a metapopulation modelling approach","volume":"8","author":"Salda\u00f1a","year":"2021","journal-title":"R. Soc. Open Sci."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"e1002470","DOI":"10.1371\/journal.pcbi.1002470","article-title":"Determinants of sexual network structure and their impact on cumulative network measures","volume":"8","author":"Schmid","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"158.e14","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1007\/s10461-019-02701-7","article-title":"A conjoint analysis of the acceptability of targeted long-acting injectable antiretroviral therapy among persons living with HIV in the U.S","volume":"24","author":"Simoni","year":"2020","journal-title":"AIDS Behav."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"e2016623118","DOI":"10.1073\/pnas.2016623118","article-title":"Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control","volume":"118","author":"Sneppen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1093\/aje\/kwy191","article-title":"Reassessing the global mortality burden of the 1918 influenza pandemic","volume":"187","author":"Spreeuwenberg","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.abf9302","article-title":"Prospective mapping of viral mutations that escape antibodies used to treat COVID-19","volume":"371","author":"Starr","year":"2021","journal-title":"Science"},{"key":"ref158","first-page":"52","article-title":"HIV sequence database","volume-title":"Dictionary of Bioinformatics and Computational Biology","author":"Stoesser","year":"2004"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1002\/sim.2432","article-title":"Bayesian back-calculation using a multi-state model with application to HIV","volume":"24","author":"Sweeting","year":"2005","journal-title":"Stat. Med."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"eaau5485","DOI":"10.1126\/scitranslmed.aau5485","article-title":"The 1918 influenza pandemic: 100 years of questions answered and unanswered","volume":"11","author":"Taubenberger","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"a038695","DOI":"10.1101\/cshperspect.a038695","article-title":"The 1918 influenza pandemic and its legacy","volume":"10","author":"Taubenberger","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref163","doi-asserted-by":"publisher","first-page":"P276","DOI":"10.1186\/1742-4690-9-S2-P276","article-title":"Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX\u00ae-B DNA vaccine in a phase I trial","volume":"9","author":"Tebas","year":"2012","journal-title":"Retrovirology"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1473-3099(10)70186-9","article-title":"Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease","volume":"11","author":"Tebit","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.coviro.2017.12.001","article-title":"The impact of HIV-1 within-host evolution on transmission dynamics","volume":"28","author":"Theys","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"e00539-19","DOI":"10.1128\/AAC.00539-19","article-title":"An evolutionary model-based approach to quantify the genetic barrier to drug resistance in fast-evolving viruses and its application to HIV-1 subtypes and Integrase inhibitors","volume":"63","author":"Theys","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1473-3099(02)00343-2","article-title":"Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy","volume":"2","author":"Thomson","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"e1008892","DOI":"10.1371\/journal.pcbi.1008892","article-title":"On realized serial and generation intervals given control measures: the COVID-19 pandemic case","volume":"17","author":"Torneri","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12916-020-01636-4","article-title":"A prospect on the use of antiviral drugs to control local outbreaks of COVID-19","volume":"18","author":"Torneri","year":"2020","journal-title":"BMC Med."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref172","year":"2022"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/postgradmedj-2020-138234","article-title":"Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)","volume":"96","author":"Umakanthan","year":"2020","journal-title":"Postgrad. Med. J."},{"key":"ref174","year":"2021"},{"key":"ref175","year":"2022"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/vaccines2030624","article-title":"Developments in viral vector-based vaccines","volume":"2","author":"Ura","year":"2014","journal-title":"Vaccine"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2143","article-title":"Drugs against SARS-CoV-2: what do we know about their mode of action?","volume":"30","author":"Valle","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/COH.0000000000000443","article-title":"Insights on transmission of HIV from phylogenetic analysis to locally optimize HIV prevention strategies","volume":"13","author":"Van De Vijver","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00002030-199701000-00012","article-title":"An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa","volume":"11","author":"van Harmelen","year":"1997","journal-title":"AIDS"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"e1000275","DOI":"10.1371\/journal.pmed.1000275","article-title":"Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling","volume":"7","author":"Van Kerkhove","year":"2010","journal-title":"PLoS Med."},{"key":"ref181","first-page":"77","article-title":"European recommendations for the clinical use of HIV drug resistance testing: 2011 update","volume":"13","author":"Vandamme","year":"2011","journal-title":"AIDS Rev."},{"key":"ref182","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/vaccines8040680","article-title":"Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats","volume":"8","author":"Vrba","year":"2020","journal-title":"Vaccine"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"587269","DOI":"10.3389\/fcimb.2020.587269","article-title":"SARS-CoV-2: structure, biology, and structure-based therapeutics development","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref185","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/01.aids.0000232229.96134.56","article-title":"Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context","volume":"20","author":"Wegbreit","year":"2006","journal-title":"AIDS"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref187","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref188","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts a randomized controlled trial","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"key":"ref189","year":"2004"},{"key":"ref190","year":""},{"key":"ref191","year":""},{"key":"ref192","year":""},{"key":"ref193","year":""},{"key":"ref194","year":""},{"key":"ref195","year":""},{"key":"ref196","year":""},{"key":"ref197","year":"2021"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1038\/s41467-021-21747-7","article-title":"The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19","volume":"12","author":"Willem","year":"2021","journal-title":"Nat. Commun."},{"key":"ref199","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1371\/journal.pmed.0030262","article-title":"The potential impact of male circumcision on HIV in sub-Saharan Africa","volume":"3","author":"Williams","year":"2006","journal-title":"PLoS Med."},{"key":"ref200","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3201\/eid1603.091216","article-title":"School closure and mitigation of pandemic (H1N1) 2009, Hong Kong","volume":"16","author":"Wu","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref201","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1006736","article-title":"Safety and effectiveness of a 2009 H1N1 vaccine in Beijing","volume":"363","author":"Wu","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref202","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref203","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1128\/JVI.00959-08","article-title":"Structural characterization of the 1918 influenza virus H1N1 neuraminidase","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"ref204","doi-asserted-by":"publisher","first-page":"816778","DOI":"10.3389\/fmicb.2022.816778","article-title":"Inactivated vaccines against SARS-CoV-2: neutralizing antibody titers in vaccine recipients","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref205","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-021-03361-1","article-title":"SARS-CoV-2 spike D614G change enhances replication and transmission","volume":"592","author":"Zhou","year":"2021","journal-title":"Nature"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.889643\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T15:25:50Z","timestamp":1700666750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.889643\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":205,"alternative-id":["10.3389\/fmicb.2022.889643"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.889643","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"article-number":"889643"}}